News | September 02, 2010

Radiofrequency Ablation for AF May Cause Esophageal Injury

September 2, 2010 – New research released this week is the first to find both anatomical and procedural considerations that can lead to the creation of esophageal ulcerations (ESUL) after radiofrequency ablation of atrial fibrillation (AF). According to a study published in the September issue of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, patients at high risk for esophageal injury can be identified based on pre-acquired multi-slice computed tomography. The study is the largest to provide serial endoscopy data on the esophagus after radiofrequency ablation.

The study population consisted of 275 patients admitted to the Elisabethinen University Teaching Hospital Linz for pulmonary vein (PV) isolation from September 2007 to June 2009. A standardized ablation approach using a 25-W energy maximum at the posterior left atrial (LA) wall without esophagus visualization, temperature monitoring or intracardiac ultrasound was performed. All patients were screened for evidence of the development of ESUL 24 hours after RFA. ESUL did not develop in any patient who had PV isolation alone.

Study analysis revealed that the greatest anatomical risk factor for the development of ESUL was a small LA-to-esophageal distance. Within the study population, the total risk of ulcers developing was 2.2 percent. Wall legions were classified as ESUL created by radiofrequency ablation by means of localization and endosonographic appearance. Anatomical factors included in the multivariate model were LA-to-esophageal distance, type of AF and additional LA linear lesions. LA-to-esophageal distance was the only independent predictor of the development of ESUL.

“It has been speculated that esophageal ulcerations can lead to atrioesophageal fistula, which is a rare but life-threatening complication of AF,” said lead author Martin Martinek, M.D., Public Hospital Elisabethinen, Academic Teaching Hospital of the University of Innsbruck and Graz in Austria. “Our study aimed to discover risk factors that can lead to injuries of the esophagus due to radiofrequency ablation. In doing so, we may better identify high-risk patients to determine the most appropriate course of action for RFA and its followup.”

For more information:

Related Content

Stereotaxis Receives Regulatory Approval of e-Contact Module in Canada
Technology | Ablation Systems| December 08, 2017
December 7, 2017 — Stereotaxis Inc.
CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems| October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems| October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biosense Webster multi-electrode RF ablation balloon

Biosense Webster's multi-electrode RF ablation balloon with irrigation. The system allows operators to change the energy levels of each electrode to avoid damaging sensitive underlying critical structures like the esophagus or phrenic nerve.

Feature | Ablation Systems| May 17, 2017 | Dave Fornell
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigatio
Abbott Announces CE Mark for New Cardiac Ablation Catheter
News | Ablation Systems| May 10, 2017
Abbott announced CE Mark of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, developed to make it easier...
Medtronic, expanded indication, Freezor Xtra Cryoablation Catheter, AVNRT, atrioventricular nodal re-entrant tachycardia
Technology | Ablation Systems| February 16, 2017
Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cryoablation Catheter...
CardioFocus, HeartLight Excalibur Balloon, 22nd Annual AF Symposium, atrial fibrillation, initial clinical evaluation
News | Ablation Systems| January 25, 2017
CardioFocus Inc. recently announced the initial clinical evaluation of the HeartLight Excalibur Balloon, a next-...
catheter ablations, atrial fibrillation, stroke risk, Intermountain Medical Center Heart Institute study, AHA Scientific Sessions, American Heart Association
News | Ablation Systems| November 14, 2016
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation lower their long-term risk of...
Overlay Init